device

World’s First InterAtrial Shunt Designed to Treat Heart Failure.

Corvia Medical, Inc., is dedicated to revolutionizing the treatment of heart failure with first-in-class structural heart devices. The company has developed the world’s first transcatheter device designed to treat heart failure with preserved (HFpEF) or mid-range (HFmrEF) ejection fraction, previously known as diastolic heart failure (DHF). The innovative InterAtrial Shunt Device (IASD®) is designed to reduce elevated left atrial pressure (LAp), which is the main cause of heart failure symptoms.

watch-video

Clinical Study Information

Corvia Medical has completed enrollment in the REDUCE LAP HF I study and is currently enrolling the REDUCE LAP-HF II study. To learn more, visit treatmyheartfailure.com.

Hear From Our Sites

Patients Eager to Test Device That Could Ease Heart Failure Symptoms

Ohio State Evaluates First Transcatheter Implant for Diastolic Heart Failure